Should You Buy A Share Of The £15bn Dividends Of Royal Dutch Shell Plc, GlaxoSmithKline plc And BHP Billiton plc?

Now could be a great time to invest in high-yield heavyweights Royal Dutch Shell Plc (LON:RDSB), GlaxoSmithKline plc (LON:GSK) and BHP Billiton plc (LON:BLT).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Megacaps Royal Dutch Shell (LSE: RDSB) (NYSE: RDS-B.US), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and BHP Billiton (LSE: BLT) are among the most prodigious cash-generators in the FTSE 100.

Together, the three firms are set to dish out £15bn of dividends to shareholders this year.

Not only is the gross payout figure mind-bogglingly huge, but also, with the shares of all three companies trading around 52-week lows, the yields on offer to investors today are of mammoth proportions.

BHP Billiton

BHP Billiton’s shares were making highs of above £20 last summer, but we’ve seen them below £13 on occasions in recent months. The mining giant is expected to pay a dividend of around 80p for its financial year ending 30 June. That gives a yield of 6.15% at a share price of £13.

Of course, over-supply and low prices in the mining sector are hurting BHP Billiton’s earnings at the moment, which means dividend cover is falling significantly: cover of just 1.15 times is forecast for the current year. Nevertheless, management is sticking to its “progressive” dividend policy. That’s somewhat surprising, because even a flat dividend next year would be uncovered by forecast earnings.

However, BHP Billiton has some flexibility to continue paying a dividend through the trough of the earnings cycle, by managing the business to maximise cash flow and increasing borrowings for a period, if necessary.

Royal Dutch Shell

Mining isn’t the only area of the resources sector seeing over-supply and low prices. The same is true for oil. Shares of supermajor Royal Dutch Shell were trading above £25 last summer, but have recently dipped below £19, which is a level not seen since 2011.

Shell intends to maintain its dividend at $1.88 (about 123p) a share this year — and to pay “at least that amount” in 2016 — giving a yield of 6.5% at a share price of £19. Earnings forecasts give skinny dividend cover of 1.05 for this year. However, analysts expect a healthy improvement in Shell’s bottom line next year, which would lift cover to 1.4.

Furthermore, Shell’s agreed takeover of BG Group bodes well for the longer-term future.

GlaxoSmithKline

Pharmaceuticals giant GlaxoSmithKline isn’t exposed to the great macro trade winds that propel or pull back the earnings of resources companies, such as BHP Billiton and Shell. However, the pharma sector has had pressures of its own in recent years with governments tightening health budgets, a spate of patent expiries and competition from generic drugs.

Glaxo’s earnings have fallen for the last two years, and the company has recently decided to peg its dividend at 80p a year for 2015-17. The company has also dropped a previous plan for an c. 80p capital return to shareholders this year in favour of a c. 20p special dividend.

Glaxo’s 80p ordinary dividend gives a yield of 5.8% at current share-price lows of under £14, compared with highs of above £16 as recently as April. This year’s dividend could be only just covered by earnings. However, the earnings decline is expected to bottom out, with double-digit growth for 2016, lifting dividend cover to 1.1 times. Glaxo has also guided on mid-to-high single-digit earnings growth through to 2020. That would be capable of supporting a return to above-inflation dividend increases and strengthening dividend cover.

Looking to the long term

Earnings of these three companies are currently at a low ebb, and myopic Mr Market has pushed their share prices down and lifted their dividend yields up. Of course, there are always risks in taking a contrarian position, but going against the herd can reap big rewards.

I believe the long-term prospects for Billiton, Shell and Glaxo are such that backing them today — while their shares are depressed and their yields high — could pay off handsomely in the decades to come.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »